Abstract
Amyloid B-protein/amyloid A4 is a peptide present in the neuritic plaques, neurofibrillary tangles and cerebrovascular deposits in patients with Alzheimer's disease and Down's syndrome (trisomy 21)1–4 and may be involved in the pathogenesis of Alzheimer's disease5. Recent molecular genetic studies have indicated that amyloid protein is encoded as part of a larger protein by a gene on human chromosome 21 (refs 6–9). The amyloid protein precursor (APP) gene is expressed in brain and in several peripheral tissues, but the specific biochemical events leading to deposition of amyloid are not known. We have now screened complementary DNA libraries constructed from peripheral tissues to determine whether the messenger RNA encoding APP in these tissues is identical to that expressed in brain, and we identify a second APP mRNA that encodes an additional internal domain with a sequence characteristic of a Kunitz-type serine protease inhibitor. The alternative APP mRNA is present in both brain and peripheral tissues of normal individuals and those with Alzheimer's disease, but its pattern of expression differs from that of the previously reported APP mRNA.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Glenner, G. G. & Wong, C. W. Biochem. biophys. Res. Commun. 122, 1131–1135 (1984).
Kidd, M., Allsop, D. & Landon, M. Lancet i, 278 (1985).
Masters, C. L. et al. EMBO J. 4, 2757–2763 (1985).
Masters, C. L. et al. Proc. natn. Acad. Sci. U.S.A. 82, 4245–4249 (1985).
Roch, M., Tomlinson, G. & Blessed, G. Nature 209, 109–110 (1966).
Tanzi, R. E. et al. Science 235, 880–885 (1987).
Kang, J. et al. Nature 325, 733–736 (1987).
Goldgaber, D., Lerman, M. I., McBride, W., Saffiotti, U. & Gajdusek, D. C. Science 235, 877–879 (1987).
Robakis, N. K., Ramakrishna, N., Wolfe, G. & Wisniewski, H. M. Proc. natn. Acad. Sci. U.S.A. 84, 4190–4193 (1987).
Tanzi, R. E. et al. Nature 329, 156–157 (1987).
Kunitz, M. J. Gen. Physiol. 10, 311–320 (1947).
Hochstrasser, K., Schonberger, O. L., Rossmanith, I. Wachter, E. Hoppe-Seyler's Z. physiol. Chem. 362, 1357–1362 (1981).
Kaumeyer, J. F., Polazzi, J. O. & Kotick, M. P. Nucleic Acids Res. 14, 7839–7850 (1986).
Hochstasser, K., Albrecht, G. J., Schonberger, O. I. & Wachter, E. Hoppe-Seyler's Z. physiol. Chem. 364, 1689–1696 (1983).
Fioretti, E., Iacopino, G., Angeletti, M., Barra, D. & Ascoli, F. J. biol. Chem. 260, 11451–11455 (1985).
Albrecht, G. J. Hochstrasser, K. & Salier, J.Ph. Hoppe-Seyler's Z. physiol. Chem. 364, 1703–1708 (1983).
Bromke, B. J. & Kueppers, F. Biochem. Med. 27, 56–67 (1982).
Hochstrasser, K., Reisinger, P., Albrecht, G. J., Wachter, E. & Schonberger, O. L. Hoppe-Seyler's Z. physiol. Chem. 365, 1123–1130 (1984).
Reisinger, P., Hochstrasser, K., Albrecht, G. J., Lempart, K. & Salier, J.Ph. Biol. chem. Hoppe-Seyler 366, 479–483 (1985).
Ghiso, J., Jensson, O. & Frangione B. Proc. natn. Acad. Sci. U.S.A. 83, 2974–2978 (1986).
Sanger, F., Nicklen, S. & Coulson, A. R. Proc. natn. Acad Sci. U.S.A. 74, 5463–5467 (1977).
Tabor, S. & Richardson, C. C. Proc. natn. Acad. Sci. U.S.A. 84, 4767–4771 (1987).
Travis, J. & Salvesen, G. S. A. Rev. Biochem. 52, 655–709 (1983).
Anderson, S. & Kingston, B. I. Proc. natn. Acad. Sci. U S.A. 80, 6838–6842 (1983).
Wachter, E. & Hochstrasser, K. Hoppe-Seyler's Z. physiol. Chem. 362, 1351–1355 (1981).
Takahashi, H., Iwanaga, S., Kitagawa, T., Hokama, Y. & Suzuki, T. J. Biochem., Tokyo 76, 721–733 (1974).
Tschesche, H. & Dietl, T. Eur. J. Biochem. 58, 439–451 (1975).
Neve, R. L., Harris, P., Kosik, K. S., Kurnit, D. M. & Donlon, T. A. Molec. Brain Res. 1, 271–280 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tanzi, R., McClatchey, A., Lamperti, E. et al. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature 331, 528–530 (1988). https://doi.org/10.1038/331528a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/331528a0
This article is cited by
-
Alternative splicing in neurodegenerative disease and the promise of RNA therapies
Nature Reviews Neuroscience (2023)
-
Metabolic disorder in Alzheimer’s disease
Metabolic Brain Disease (2021)
-
Differential transcript usage unravels gene expression alterations in Alzheimer’s disease human brains
npj Aging and Mechanisms of Disease (2021)
-
The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer’s Disease
Molecular Neurobiology (2016)
-
Platelet dysfunction in hypercholesterolemia mice, two Alzheimer’s disease mouse models and in human patients with Alzheimer’s disease
Biogerontology (2015)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
